EDHO2022

Scope and Purpose

This workshop will provide a forum for scientists, regulatory authorities, ophthalmologists and transfusion experts on the usage, quality, clinical need and manufacture of eye drops from human origin. Selected scientific lectures from well-known experts will be presented. Key discussions to find commonalities in production and quality issues include the latest scientific knowledge. The aim is to reach consensus on classification, validation and standardization of these products. The active participation from various regulatory agencies will also be an important emphasis of this workshop.

Ample time shall be provided for a highly stimulating personal discussion:

• To exchange knowledge between eye specialists, transfusion specialists and regulators
• To enhance knowledge of eye physicians on properties of EDHO and its regulatory requirements
• To enhance knowledge of transfusion specialists on serum eye drops, the clinical need, patient´s needs
• To develop a common ground for the regulation of EDHO

​

The Organisers

Thierry Burnouf

Global Blood Safety Working Party Secretary, Cellular Therapies Treasurer, Vice-Dean, Taipei Medical University, Taiwan

×

Thierry Burnouf

Global Blood Safety Working Party Secretary, Cellular Therapies Treasurer, Vice-Dean, Taipei Medical University, Taiwan

Christian Gabriel

Vice Chair of the Cellular Therapies Working Party, Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, Vienna, Austria

×

Christian Gabriel

Vice Chair of the Cellular Therapies Working Party, Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, Vienna, Austria

Reinhard Henschler

Cellular Therapies Working Party Chair, Director, Institute of Transfusion Medicine bei University Hospital Leipzig, Germany

×

Reinhard Henschler

Cellular Therapies Working Party Chair, Director, Institute of Transfusion Medicine bei University Hospital Leipzig, Germany

Jutta Horwath-Winter

×

Jutta Horwath-Winter

Mickey Koh

Cellular Therapies Working Party Past Chair, Director, Stem Cell Transplantation at St George's hospital and Medical School, London, UK

×

Mickey Koh

Cellular Therapies Working Party Past Chair, Director, Stem Cell Transplantation at St George's hospital and Medical School, London, UK

Email:

[email protected]

Denese Marks

ISBT Regional Director Western Pacific, ISBT BC WP Chair, Associate Professor, University of Sydney, Australia; Australian Red Cross LifeBlood Service

×

Denese Marks

ISBT Regional Director Western Pacific, ISBT BC WP Chair, Associate Professor, University of Sydney, Australia; Australian Red Cross LifeBlood Service

Regional Director Western Pacific (2020-2024)

Denese Marks earned her PhD at the University of Technology, Sydney, followed by post-doctoral fellowships at the University of Vienna, the University of Melbourne and the Institute of Child Health at Great Ormond Street Hospital in London, as well as working in the biotechnology industry. Denese is the National Leader for Product Development at Australian Red Cross LifeBlood, where her research focuses on developing new blood products to meet patient needs, improving blood component processing and storage, platelet and red cell cryopreservation, pathogen inactivation and clinical trials of blood products. She is also an adjunct Associate Professor with the University of Sydney School of Medicine. Denese is a Section Editor for Vox Sanguinis, a scientific member of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative and a member of the Executive Committee for the ISBT Cellular Therapies Working Party.

Katharina Schallmoser

Paracelsus Medical University Salzburg, Austria

×

Katharina Schallmoser

Paracelsus Medical University Salzburg, Austria

Any questions? Contact us at [email protected]